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Before we had the tools to systematically
interrogate variation throughout the hu-
man genome, there were two schools of
thought in sometimes mortal combat. As
Robert Shields reminds us in his editorial,
some argued for the common-disease
common-variant model (CD-CV), postu-
lating an important role for common
variants in common disease, while others
argued that a great diversity of different
rare variants were most likely the primary
drivers of common diseases. The Interna-
tional HapMap Project, and the genome-
wide association studies (GWAS) it en-
abled, were motivated in part by the CD-
CV model.
Before GWAS, strong theoretical argu-
ments were marshaled in support of either
rare variants [1] or common variants [2],
but few data were available to resolve the
dispute. GWAS changed that by allowing
us a (nearly) comprehensive evaluation of
the role of common variation in human
disease.
It is worth noting that GWAS have
been serving their intended purpose re-
markably well. It is generally agreed that
GWAS successfully represent most of the
common variation in the human genome.
Moreover, the sample sizes that have now
been analyzed for most common diseases
would allow detection of most of the
common variants that have even a modest
impact on disease risk. For many common
diseases, however, the cumulative impact
of common variants implicated to date is
modest, leading to the ‘‘missing heritabil-
ity’’ question [3].
Another key observation has been the
pathogenicity of copy number variants
(CNVs). Here, we see variants that are
rare by anyone’s definition that have a
dramatic impact on risk for many neuro-
psychiatric diseases [4]. Indeed, the effect
sizes that have been associated with some
of these rare risk factors are dramatically
beyond what many would have previously
considered realistic for such complex
diseases. Together, these two observations,
amongst others, led me to wonder whether
we were interpreting the results of GWAS
correctly.
In our first paper evaluating the prop-
erties of synthetic associations [5], we
sought to address a very simple question:
if a significant GWAS signal is observed, is
it justified to infer that a common variant
must be responsible for that signal? Before
our paper, many researchers explicitly or
implicitly assumed just that. Our paper
investigated the properties of synthetic
associations in the context of GWAS,
asking whether the sample sizes and
significance thresholds being considered
were such that rare variants could reason-
ably be considered as candidates for
creating some of the GWAS signals. We
concluded that rare variants can easily
create genome-wide significant associa-
tions credited to more common variants
given the sample sizes being considered
today, and it is therefore unjustified to
assume that a GWAS signal must reflect
the effect of a common variant. We also
noted the practical implication that if an
association is indeed synthetic, it is possible
that the causal variant is much farther
away from the discovery variant than
would be possible if the cause is a common
variant. Although we can show that rare
variants could create synthetic associations
credited to common variants, this does not
allow us to determine the proportion of
GWAS signals that are synthetic. In my
view, this is a question that will only be
answered empirically by tracking down
the causal variants (almost certainly
through sequencing).
Before addressing the specific comments
by Anderson et al. and Wray et al. on our
work, it is worth clarifying a few points
that I consider to be essentially beyond
reasonable argument:
1) Most of the reported GWAS
signals reflect true genetic as-
sociations
Some have recently suggested that
many of the reported GWAS signals
may be spurious in some sense. I
have no sympathy for this perspec-
tive. I am wholly convinced that most
of the broadly accepted GWAS
signals reflect the presence of one or
more real inherited genetic risks that
are associated with the discovery
variant. The suggestion that some of
the GWAS signals are synthetic in no
way calls into question the reality of
GWAS signals.
2) GWAS are a highly effective tool
and were well worth doing
I consider both the HapMap project
and the resulting GWAS phase to
have provided crucial information
about the genetic architecture of
human diseases, and I consider it
to have been the natural experiment
to do.
3) GWAS have made important
discoveries
While the ultimate utility of many
GWAS signals has been severely
limited by the inability to move
from a GWAS signal to causal
variants in most cases, or by their
poor diagnostic/prognostic value,
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discoveries that are of uncontested
interest biologically and may have
clinical significance.
To these points of agreement we might
add one more:
4) Synthetic associations are plau-
sible
Neither Anderson et al. nor Wray
et al. contest the central fact that
synthetic associations can work
more or less as we described them.
That is, given sample sizes considered
today, variants substantially more
rare than discovery variants can
create signals of associations credited
to common variants. Moreover, un-
der synthetic associations, it is possi-
ble for the variants to be at some
considerable physical distance from
the associated variant.
These are then the points of agree-
m e n t .A n d e r s o ne ta l .a n dW r a ye ta l .
both marshal a range of different argu-
ments to conclude that synthetic associa-
tions as we describe them, while possible,
are unlikely to be responsible for many of
the GWAS signals that have been report-
ed. They offer two primary arguments.
Anderson et al. argue that variants that
would drive synthetic associations should
have been detected in linkage analyses for
common diseases, while Wray et al. argue
that the distribution of allele frequencies
of variants implicated in GWAS is
inconsistent with a model of synthetic
associations that would favor association
being credited to the lower frequency
classes amongst the SNPs interrogated in
GWAS. I address these key arguments in
turn.
Does the Absence of Widely-
Accepted Linkage Evidence
Rule Out Synthetic Association?
The argument is that variants with
large enough effect sizes to drive synthet-
ic associations should be detected in
linkage studies, so if they are in the
genome, why haven’t we found them?
There are two fundamental problems
with this argument. The first is that our
understanding of what linkage does and
does not permit is more limited than
suggested, in part because of how vari-
able linkage results and interpretations
have been. It is certainly true that relative
risks above 4 should generate a strong
linkage signal. But what has and has not
been shown by linkage is more equivocal
than implied. For example, it has been
reported that most chromosomes have
been implicated in linkage studies of
bipolar disease and schizophrenia [6].
What fraction of these are real signal and
what fraction are false positive? There is
simply no way to know. CNVs are also
instructive in this context. Even though
some have very high relative risks and
some are inherited, they were not ‘‘de-
tected’’ in linkage studies (perhaps in part
because of their nonspecifity).
The second problem with the argument
is perhaps the stronger one. Even granting
that the absence of widely accepted
evidence in linkage should be taken as
evidence of the absence of variants with
relatively strong effects, this does not in
fact rule out synthetic associations simply
because of the extraordinarily large sam-
ple sizes used in many GWAS. We
centered our analyses around a sample
size of 2,000 cases and 2,000 controls. We
showed that for such sample sizes it is very
easy to get a synthetic association for a
relative risk of 4, whether there was one or
several rare variants in the range of
frequencies considered (.005, .02). But
even for this sample size and a relative
risk of only 2, a small proportion of the
gene genealogies still result in genome-
wide significant associations credited to
common variants. So what does this
mean? It means that if there are many
such rare variants of modest impact in the
genome they will still create a few signals,
even if most of them do not.
In fact, however, GWAS sample sizes
for many traits have dramatically exceed-
ed this size, meaning that weaker and
weaker effects of rare variants will still
easily create genome-wide significant syn-
thetic associations. Indeed, if one simulates
25,000 cases versus 25,000 controls, rare
variants with a relative risk of only 2 will
usually create genome-wide significant
synthetic associations (unpublished data).
This observation is really just a testament
to the singular power of detection of
contemporary GWAS.
In short, even if we presume that all
past linkage studies have been performed
and interpreted correctly, these argu-
ments make clear that it is easy to imagine
a fair number of rare variants escaping
linkage detection and yet driving synthetic
associations, and this becomes increasing-
ly likely as the sample size increases.
Thus, we may well expect that synthetic
associations make a relatively greater con-
tribution to the signals observed in the
more recent studies that have employed
exceptionally large sample sizes, for ex-
ample for lipids [7], body mass index [8],
and height [9].
Does the Allele Frequency
Distribution of Associated
Variants Rule Out Synthetic
Associations?
Wray et al., on the other hand, argue
that if most associations responsible for
GWAS were synthetic, then the implicated
common variants would be rarer than
what has been observed. To arrive at this
conclusion they simulate synthetic associ-
ations using the same approach we used,
and sample only a subset of variants in
order to match the allele frequency
distribution of the variants on GWAS
chips. They then show that under synthet-
ic associations the mean frequency of the
most associated genotyped SNPs is 0.13
for one rare causal variant and 0.3 for up
to 18 causal variants. The authors argue
(rightly) that this distribution is different
from the distribution of allele frequencies
of the discovery variants in GWAS, which
tend to be the more common variants. But
what may we conclude from this formally?
If we assume that the simulated allele
frequency distribution the authors use
actually matches all the various GWAS
chips used in various studies, and if we
further assume that investigators have no
biases in terms of what variants they
choose to follow up in replication analyses,
then we may conclude that the distribution
of allele frequencies of discovery variants is
inconsistent with a model in which
synthetic associations are responsible for
all GWAS signals. That is, we need to
have at least some of the GWAS signals due
to common variants in order to pull the
overall distribution upward from what
would be expected from an absolutely
rare-only model for all associations. As far
as I am aware, no one has ever articulated
a rare-only model for all GWAS signals.
The natural question then is: what pro-
portion of the GWAS signals would have
to be due to common variants to perturb
the overall allele frequency distribution
away from the expectation of a rare-only
model? This has not been investigated, but
it seems quite likely that such an investi-
gation would leave open plenty of scope
for synthetic associations to contribute to
some, and perhaps many, signals, as we
suggested [5]. Thus, of the hundreds of
GWAS signals now listed on the National
Human Genome Research Institute Web
site, might synthetic associations be re-
sponsible for a substantial number of
signals without pulling the entire allele
frequency distribution out of the common
range? It would certainly seem so.
In addition to these central arguments,
both Anderson et al. and Wray et al. make
PLoS Biology | www.plosbiology.org 2 January 2011 | Volume 9 | Issue 1 | e1001008a number of secondary arguments. Wray
et al. also highlight the analyses of the
International Schizophrenia Consortium
(ISC), and suggest that we implied that a
rare-only model is sufficient to explain
their results. Addressing the inferences of
the ISC is beyond the scope of this
response, but it is worth clarifying that
what I question is that the ISC analyses
prove ‘‘a substantial polygenic component
to the risk of schizophrenia involving
thousands of common alleles of very small
effect’’, as they stated [10]. Under a model
involving a contribution of synthetic
associations, some of that signal credited
to thousands of common alleles of tiny
effect could be coming from rare variants
of larger effect, and I cannot see how this
could be ruled out.
The authors also note that many
GWAS for height are near genes influenc-
ing skeletal growth. This, however, in no
way points towards the cause of the
associations being rare or common. We
have shown that if the causal variant (or
variants) is rare, then it is possible for the
discovery variant to be at some distance
removed from the causal variant [5].
Nevertheless, there is no reason to assume
that when the causal variant is rare, the
discovery variant should be preferentially
far from the causal variant. Indeed, the
expected association between any causal
variant (rare or otherwise) and other
variants decreases with distance. Simply
because the causal can be farther away
under synthetic associations does not
mean it always is. Thus, the proximity of
skeletal growth genes in the height GWAS
data is perfectly consistent with either rare
or common variants driving those signals.
Finally, Wray et al. point out that for
the genetic models we simulated, if all
associations for a given trait were synthet-
ic, then this would impose a constraint on
the total number of genomic regions that
could be so mapped before the full genetic
control of a trait were explained (because
the genetic contribution of a region is
greater than it appears if the source of the
signal is synthetic). This constraint, how-
ever, still easily allows the possibility that
many of the reported signals are synthetic
and does not lend itself to any estimator of
what proportion of signals for most traits
might be synthetic. In their commentary,
Anderson et al. highlight the fact that the
WTCCC sequenced 16 GWAS regions
(hundreds of kilobases to a Mb around
significant SNPs) and found no rare causal
variants. This claim is a little hard to
assess, as the analysis has not been
published so far as I am aware, and only
reported at meetings beginning in 2009.
What is interesting, however, is that these
follow-up efforts not only found no rare
causal variants, they also found no com-
mon causal variants. While rare variants
may be easier to recognize than common
ones, they also may be much farther away
from the discovery variant and they may
be present on only a small proportion of
the chromosomes that carry the risk allele
of the discovery common variant. For
these reasons, failure to find either rare or
common causal variants does not consti-
tute strong evidence for or against syn-
thetic associations.
Anderson et al. also note that many of
the GWAS signals are common across
populations, suggesting they are due to
common variants. There is, however, no
guarantee that synthetic associations
would always be population specific. It is
easy to imagine relatively rare variants
sometimes being shared amongst different
Eurasian populations, and sometimes not
being shared. Moreover, even when the
rare variants are population specific, it is
possible that similar signals are sometimes
created by different rare variants in
different populations in the same genome
regions, and only detailed characterization
of the pattern of association in different
populations could reveal that.
So where does all this leave us? More or
less where we started. It is unjustified to
assume that any given GWAS signal is due
to a common variant, as was usually done
before our work. Equally, it is unjustified
to assume that any given GWAS signal
must be synthetic in origin. In fact, the
proportion of GWAS signals that are
synthetic in origin depends on the genetic
architecture of human traits, and this
architecture remains largely unknown.
What we do know is that common variants
of large effect have not been observed for
many of the common diseases studied by
GWAS, and that even the common
variants that have been associated cannot
be simply assumed to reflect the effect of a
common variant until that variant is
actually identified and shown to be causal.
Thus, an answer to the question of what is
responsible for GWAS signals will only
emerge as we track down the precise gene
variants that influence human traits and
then put them back into the context of
GWAS signals to settle what may be, by
then, simply an interesting historical
footnote. On the basis of all current
evidence, I certainly lean toward thinking
that rarer variants are generally more
important than common ones in common
diseases, although this is ultimately an
empirical question. Our work on synthetic
associations was designed to show that
they can happen, and since they can
happen quite readily, I believe they must
be responsible for some GWAS signals,
and perhaps many. But we have no way of
knowing whether it is a majority or
minority. Time will tell.
Finally, it is worth reemphasizing that
even for those GWAS signals that are
synthetic, they still make a valuable
contribution to work going forward. De-
spite its limitation in representing mostly
common variation, there is one critically
important feature of GWAS. It is a highly
accurate and well understood experiment.
A GWAS signal emerging from a properly
conducted study means there is at least
one causal variant somewhere relatively
nearby. This cannot be said about se-
quence data, which currently can some-
times feel more like the Wild West than
the laboratory. GWAS signals, be they
synthetic in origin or not, give us a key
foothold in the early days of interpretation
of complete human-genome sequence
data. Sequencing is and should be the
future of discovery genetics, but as we
charge into that future, I am glad we are
armed with a few GWAS signals to aid in
the interpretation.
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